SCHEMBL6837353

SCHEMBL6837353

OC(O)[C@H]1C[C@@H]1c1ccc(Br)cc1

nearest known ligand 0.52

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 10/20 0.52
MAOB P27338 7/20 0.52
KCNH2 Q12809 2/20 0.52
RCOR1 Q9UKL0 2/20 0.52
KDM1B Q8NB78 1/20 0.52
HTR2C P28335 2/20 0.46
HTR2B P41595 2/20 0.46
MAOA P21397 4/20 0.41
RORC P51449 1/20 0.39
TLR2 O60603 1/20 0.37
TLR1 Q15399 1/20 0.37
SLC6A2 P23975 2/20 0.36
SLC6A4 P31645 2/20 0.36
SLC6A3 Q01959 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27520569 0.84 KDM1A (0.48) KDM1AMAOBKCNH2RCOR1KDM1B
SCHEMBL16232192 0.79 KDM1A (0.52) KDM1AHTR2CHTR2BTLR2TLR1
SCHEMBL13201373 0.75 EPHX2 (0.43) KDM1AMAOBKCNH2MAOA
SCHEMBL12295868 0.74 KDM1A (0.68) KDM1AMAOBKCNH2RCOR1KDM1B
SCHEMBL883113 0.74 KDM1A (0.68) KDM1AMAOBKCNH2RCOR1KDM1B
SCHEMBL24658449 0.73 KDM1A (0.60) KDM1AMAOBKCNH2RCOR1KDM1B
SCHEMBL27907913 0.72 KDM1A (0.44) KDM1AMAOBKCNH2RCOR1KDM1B
SCHEMBL12714992 0.70 KDM1A (0.62) KDM1AMAOBKCNH2RCOR1KDM1B
SCHEMBL27214728 0.70 KDM1A (0.62) KDM1AMAOBKCNH2RCOR1KDM1B
SCHEMBL24658830 0.70 KDM1A (0.62) KDM1AMAOBKCNH2RCOR1KDM1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012013727-A1 CYCLOPROPYLAMINE DERIVATIVES USEFUL AS LSD1 INHIBITORS ORYZON GENOMICS S.A. (ES) 2012-02-02 WO disclosed
WO-2012013728-A1 ARYLCYCLOPROPYLAMINE BASED DEMETHYLASE INHIBITORS OF LSD1 AND THEIR MEDICAL USE ORYZON GENOMICS S.A. (ES) 2012-02-02 WO disclosed